FY2026 Earnings Forecast for Plexus Issued By Zacks Research

Plexus Corp. (NASDAQ:PLXS) – Analysts at Zacks Research dropped their FY2026 earnings per share (EPS) estimates for Plexus in a research note issued to investors on Tuesday, April 14th. Zacks Research analyst Team now forecasts that the technology company will post earnings per share of $6.63 for the year, down from their prior estimate of $6.64. Zacks Research currently has a “Hold” rating on the stock. The consensus estimate for Plexus’ current full-year earnings is $5.90 per share. Zacks Research also issued estimates for Plexus’ Q1 2027 earnings at $1.70 EPS, Q3 2027 earnings at $1.88 EPS, Q4 2027 earnings at $2.05 EPS, FY2027 earnings at $7.33 EPS, Q1 2028 earnings at $1.84 EPS and FY2028 earnings at $8.03 EPS.

A number of other brokerages have also weighed in on PLXS. Williams Trading set a $195.00 target price on Plexus in a research note on Wednesday, January 28th. Benchmark restated a “buy” rating and issued a $220.00 target price on shares of Plexus in a research note on Monday, March 16th. Weiss Ratings upgraded Plexus from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Friday, March 6th. Needham & Company LLC raised their target price on Plexus from $165.00 to $206.00 and gave the company a “buy” rating in a research note on Friday, January 30th. Finally, Stifel Nicolaus raised their price target on Plexus from $150.00 to $200.00 and gave the company a “hold” rating in a report on Friday, January 30th. Three research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $194.20.

Plexus Stock Performance

Shares of NASDAQ:PLXS opened at $222.88 on Thursday. Plexus has a twelve month low of $115.35 and a twelve month high of $232.17. The firm has a market cap of $5.97 billion, a PE ratio of 34.66 and a beta of 0.75. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.75 and a current ratio of 1.59. The business has a fifty day moving average of $203.13 and a 200-day moving average of $171.53.

Plexus (NASDAQ:PLXS) last announced its earnings results on Wednesday, January 28th. The technology company reported $1.78 earnings per share for the quarter, beating analysts’ consensus estimates of $1.77 by $0.01. Plexus had a return on equity of 12.39% and a net margin of 4.28%.The company had revenue of $1.07 billion during the quarter, compared to analyst estimates of $1.07 billion. During the same period last year, the company posted $1.73 earnings per share. The firm’s quarterly revenue was up 9.6% compared to the same quarter last year. Plexus has set its Q2 2026 guidance at 1.800-1.950 EPS.

Insiders Place Their Bets

In related news, Chairman Dean A. Foate sold 5,000 shares of the firm’s stock in a transaction dated Monday, February 2nd. The stock was sold at an average price of $204.89, for a total value of $1,024,450.00. Following the transaction, the chairman owned 15,000 shares in the company, valued at $3,073,350. This trade represents a 25.00% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Angelo Michael Ninivaggi, Jr. sold 4,303 shares of the firm’s stock in a transaction dated Thursday, February 5th. The shares were sold at an average price of $203.06, for a total value of $873,767.18. Following the completion of the transaction, the chief accounting officer owned 20,099 shares in the company, valued at approximately $4,081,302.94. This represents a 17.63% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 50,995 shares of company stock valued at $10,345,971 over the last 90 days. Corporate insiders own 1.78% of the company’s stock.

Hedge Funds Weigh In On Plexus

Several hedge funds have recently added to or reduced their stakes in PLXS. Evolve Private Wealth LLC boosted its holdings in Plexus by 4.0% during the first quarter. Evolve Private Wealth LLC now owns 3,607 shares of the technology company’s stock worth $731,000 after buying an additional 138 shares during the last quarter. Balboa Wealth Partners bought a new stake in shares of Plexus in the 1st quarter valued at about $312,000. Diversified Trust Co raised its position in shares of Plexus by 11.9% in the 1st quarter. Diversified Trust Co now owns 4,991 shares of the technology company’s stock valued at $1,011,000 after acquiring an additional 530 shares during the period. Corient Private Wealth LLC raised its position in shares of Plexus by 6.1% in the 4th quarter. Corient Private Wealth LLC now owns 1,929 shares of the technology company’s stock valued at $284,000 after acquiring an additional 111 shares during the period. Finally, Caitlin John LLC bought a new position in Plexus during the 4th quarter worth approximately $408,000. Institutional investors own 94.45% of the company’s stock.

Trending Headlines about Plexus

Here are the key news stories impacting Plexus this week:

• Positive Sentiment: Plexus hit a fresh high as part of broader Nasdaq strength, helping push the stock upward on momentum and positive technical interest. Plexus (NASDAQ:PLXS) Hits Fresh High Amid Nasdaq Composite Momentum
• Positive Sentiment: Plexus set its fiscal Q2 2026 earnings release for April 29 and will host a management call April 30 — a near-term catalyst that can reinforce upside if results/guidance beat. Plexus Sets Fiscal Second Quarter 2026 Earnings Release Date
• Neutral Sentiment: CEO Todd Kelsey sold 1,500 shares on April 15 under a pre‑arranged Rule 10b5‑1 plan; the sale is small relative to his total holdings (≈1.83% decrease) and is typical of scheduled insider plans. SEC Filing – Form 4
• Negative Sentiment: Zacks Research downgraded Plexus from “strong-buy” to “hold” and trimmed several near- and medium‑term EPS estimates (small cuts to FY2026–FY2028 and Q1/Q4 2027). The downgrade and estimate reductions create headwinds for sentiment despite the company’s recent beat and guidance. Zacks Downgrade / Estimates

Plexus Company Profile

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.